Evidence map›Paper›PMID 40005345›Full record

ArticleMedicina (Kaunas, Lithuania)2025

sRAGE as a Prognostic Biomarker in ARDS: Insights from a Clinical Cohort Study.

Ana Andrijevic, Uros Batranovic, Djordje Nedeljkov, Srdjan Gavrilovic, Vladimir Carapic, Svetislava Milic, Jovan Matijasevic, Ilija Andrijevic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana AndrijevicMedical Faculty, University of Novi Sad, 21000 Novi Sad, Serbia.
Uros BatranovicIntensive Care Unit, Institute for Pulmonary Diseases of Vojvodina, 21204 Sremska Kamenica, Serbia.
Djordje NedeljkovIntensive Care Unit, Institute for Pulmonary Diseases of Vojvodina, 21204 Sremska Kamenica, Serbia.
Srdjan GavrilovicMedical Faculty, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-7752-3833
Vladimir CarapicMedical Faculty, University of Novi Sad, 21000 Novi Sad, Serbia.
Svetislava MilicIntensive Care Unit, Institute for Pulmonary Diseases of Vojvodina, 21204 Sremska Kamenica, Serbia.
Jovan MatijasevicMedical Faculty, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-2476-0763
Ilija AndrijevicMedical Faculty, University of Novi Sad, 21000 Novi Sad, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptor for Advanced Glycation End ProductsRespiratory Distress SyndromeAdultAgedBiomarkersCohort StudiesFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesSerbiaAGER protein, humanBiomarkersReceptor for Advanced Glycation End ProductsARDSbiomarkersICUmortalitysRAGE

Identifiers

PMID40005345
PMCPMC11857119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.